Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy
Clinical trial NCT05919212 · UNKNOWN
Trial details
- NCT number
- NCT05919212
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.